Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 237,829
  • Shares Outstanding, K 34,220
  • Annual Sales, $ 50,330 K
  • Annual Income, $ 1,060 K
  • 60-Month Beta 0.86
  • Price/Sales 4.68
  • Price/Cash Flow 76.01
  • Price/Book 2.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.25
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.27
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.26 +32.13%
on 05/01/20
7.34 -5.31%
on 05/12/20
+0.48 (+7.42%)
since 04/27/20
3-Month
5.26 +32.13%
on 05/01/20
11.75 -40.85%
on 02/28/20
-5.05 (-42.08%)
since 02/27/20
52-Week
5.26 +32.13%
on 05/01/20
14.00 -50.36%
on 02/18/20
-0.13 (-1.84%)
since 05/24/19

Most Recent Stories

More News
Pfenex Inc. Shareholders Who Have Suffered Losses Greater Than $50K Encouraged To Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of shareholders Pfenex Inc. ("Pfenex" or the "Company") (NYSE: PFNX) to determine whether Pfenex and certain of the Company's...

PFNX : 6.95 (+1.02%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfenex Inc. - PFNX

Pomerantz LLP is investigating claims on behalf of investors of Pfenex Inc. ("Pfenex" or the "Company") (NYSE: PFNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

PFNX : 6.95 (+1.02%)
Pfenex Reports First Quarter 2020 Results and Provides Business Update

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its proprietary protein production platform, Pfenex Expression Technology(R), to develop next...

PFNX : 6.95 (+1.02%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfenex Inc. - PFNX

Pomerantz LLP is investigating claims on behalf of investors of Pfenex Inc. ("Pfenex" or the "Company") (NYSE: PFNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

PFNX : 6.95 (+1.02%)
Shares of PFNX Down 18.9% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Pfenex Inc (AMEX:PFNX) on April 15th, 2020 at $6.89. In approximately 3 weeks, Pfenex Inc has returned 18.87% as of today's recent price of $5.59.

PFNX : 6.95 (+1.02%)
Pfenex to Announce First Quarter 2020 Financial Results on May 7

Pfenex Inc. (NYSE American: PFNX) announced today that it will report its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, May 7, 2020. Pfenex will host...

PFNX : 6.95 (+1.02%)
PFNX INVESTIGATION: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Investigation of Pfenex Inc.

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pfenex Inc. ("Pfenex" or "the Company") (NASDAQ: PFNX). Investors who purchased Pfenex...

PFNX : 6.95 (+1.02%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfenex Inc. - PFNX

Pomerantz LLP is investigating claims on behalf of investors of Pfenex Inc. ("Pfenex" or the "Company") (NYSE: PFNX) Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

PFNX : 6.95 (+1.02%)
Pfenex Inc Up 4.3% Since SmarTrend Uptrend Call (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on March 26th, 2020 at $9.32. In approximately 3 weeks, Pfenex Inc has returned 4.29% as of today's recent price of $9.72.

PFNX : 6.95 (+1.02%)
Pfenex Announces FDA Requests Additional Comparative Use Human Factors Data in Experienced Users in order to Complete PF708 Therapeutic Equivalence Determination

Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA), informed Alvogen Malta Operations Ltd., the Company's commercialization partner for PF708, via a General...

PFNX : 6.95 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade PFNX with:

Business Summary

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform...

See More

Key Turning Points

2nd Resistance Point 7.29
1st Resistance Point 7.12
Last Price 6.95
1st Support Level 6.79
2nd Support Level 6.63

See More

52-Week High 14.00
Fibonacci 61.8% 10.66
Fibonacci 50% 9.63
Fibonacci 38.2% 8.60
Last Price 6.95
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar